RayBiotech Life, Inc.
RayBiotech is a leading life sciences company providing proteomic discovery tools. RayBiotech has nearly 150 employees whose objectives are to provide excellent products and service worldwide to RayBiotech customers which include scientists in industry, academic and research institutes in 41 countries. RayBiotech is committed to accelerating customer success through innovation and leadership in the Life Sciences.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Supplies
- Market Focus:
- Globally (various continents)
- Year Founded:
- 2001
- Employees:
- 101-1000
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
Mission
RayBiotech's mission is to provide cutting-edge array technologies for the discovery of disease-related protein biomarkers and key factors, the identification of new drug targets, and the advancement of personalized medicine.
Following the completion of the human genome sequence, researchers have been able to analyze the expression of a myriad of disease-related genes; however, many diseases result from abnormal protein expression, post-translational modification, or interaction with other biomolecules. Thus, an understanding of disease states cannot be obtained from genomic research alone. Ultimately, efficient, high-throughput protein analysis offers the most promising approach to understanding and treating disease.
In 2001, RayBiotech addressed this need by introducing the first commercially available cytokine antibody array. Since then, our product lines have expanded to include hundreds of arrays and immunoassays for efficient analysis of proteins involved in inflammation, angiogenesis, apoptosis, cell growth, and signal transduction. RayBiotech's comprehensive service programs include Array Testing Services, Biomarker Discovery, Peptoid Discovery, and Custom Assay Development.
History
RayBiotech was founded in 2001 on the concept of the antibody array. The idea for making antibody arrays was born in the mind of Dr. Ruo-Pan Huang when he was a Professor at Emory University in the department of Gynecology. In late 2000, Dr. Huang was attending a conference where data based on a DNA arrays was being presented and was struck by the power of multiplex analysis. In Dr. Huang’s own lab, his graduate students and post docs were performing biochemical analysis experiments, such as Western blots and ELISAs, on individual targets, a cumbersome, time-consuming and expensive endeavor. He wondered if there was a way to bring multiplexing to his own lab to accelerate their research. With that in mind Dr. Huang began his efforts to develop arrays of antibodies to detect changes in biochemical targets in a streamlined and high-throughput format. Soon Dr. Huang’s laboratory was using both antibody and protein array technology on a regular basis. The first publication from Dr. Huang’s team implementing these biochemically-based arrays occurred in 2001.
Huang, Ruo-Pan, et al. 'Simultaneous detection of multiple cytokines from conditioned media and patient's sera by an antibody-based protein array system.' Analytical biochemistry 294.1 (2001): 55-62.
The first publication citing antibody arrays resulted in a tremendous number of inquiries for access to antibody and protein arrays, thus revealing intense market demand. Filled with an entrepreneurial spirit, Dr. Huang envisioned the opportunity to provide protein arrays to the research community at large and thus RayBiotech was born. Working from his basement, with his close family helping, RayBiotech began to grow and RayBiotech introduced the first commercially available cytokine antibody array by the end of the year.
Since that time RayBiotech’s product lines have expanded to include hundreds of arrays and immunoassays for efficient analysis of proteins involved in inflammation, angiogenesis, apoptosis, cell growth, and signal transduction. In addition, ancillary to antibody arrays RayBiotech now has the world’s largest selection of fully validated ELISA kits. RayBiotech has also added comprehensive service programs including Array Testing Services, Biomarker Discovery, Peptoid Discovery, and Custom Assay Development. RayBiotech now provides these products and services worldwide through a world class network of distributors.
Since its founding in 2001RayBiotech has grown from its humble origins to a 35,000 sq ft facility in Peachtree Corners Georgia that employs more than 50 people in high end biotechnology jobs. With the addition of GMP, GLP and ISO 13485 certifications and ever growing product lines, the future for RayBiotech continues to be bright.
Quality System Overview
RayBiotech is committed to providing the highest quality products and services to its customers and maintains medical device certification to ISO 13485 requirements as a part of these efforts. This applies to our production facility and testing services facility and adds to our compliance of GLP/GMP FDA regulations. As we look to the future, RayBiotech will continue to ensure that our products and testing services maintain and exceed this high standard of quality through our continuous improvement program.
RayBiotech Inc is committed to meeting customer requirements. RayBiotech Inc works to achieve this by:
- Implementing and maintaining a formal Quality Management System QMS.
- Designing and developing processes, products, and services related to RayBiotech’s mission statement.
- Critical management and administrative support services to the products and services of RayBiotech.
- Continually improving and strengthening product and service quality by regular review of processes and products.
- Ensuring Senior management engages in the implementation of the QMS site-wide and that all products and processes meet regulatory and quality requirements
All Raybiotech products are manufactured with high levels of production process control and rigorous quality control inspection processes to ensure each product meets specified requirements and customer expectations. Inherent with this are validated design and production process specifications, ensuring consistent product quality and reliability.
Raybiotech prides itself in providing testing services in its new state of the art GLP facility that complies with FDA regulations 21CFR58. Our commitment to quality ensures a complete testing and reporting system that is validated and designed to meet the expectations of our customer to provide accurate reproducible results using samples you provide.
Our Research Use Only products are in compliance with FDA regulations; they are freely marketed in the U.S.; and are in compliance with all U.S. laws and regulations.
Business Development
The Business Development team at RayBiotech, Inc. is committed to delivering novel products and services to our customers. To keep pace with the fast moving world of biotechnology and the life sciences we have developed a results-driven strategy for evaluating potential opportunities quickly. Our role within RayBiotech includes the following:
- Technology and Product Licensing
- Joint Partnerships and Collaborative Relationships with companies, universities and researchers
- Intellectual Property Management, including out-licensing and OEM relationships
- Legal and Contracts
We are interested in evaluating and executing upon novel technologies related to:
- Arrays
- Antibodies
- Detection Systems Including Instrumentation
- Functional Assays
- Glycans
- Peptides
- Proteins
- Posttranslational Modification
We are constantly on the lookout for new technologies, products, and services to license or acquire.